REFERENCES
1. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of
prevalence, incidence, and associated risk factors. Rev Urol.2010;12:e86-96
2. Turk C, Knoll T, Petrik A, et al. Guidelines on Urolithiasis 1–71.
Available at:http://uroweb.org/wp-content/uploads/EAU-Guidelines-Urolithiasis-2015-v2.pdf
3. Wiesenthal JD, Ghiculete D, D’A Honey RJ, et al. A comparison of
treatment modalities for renal calculi between 100 and 300 mm2: are
shockwave lithotripsy, ureteroscopy and percutaneous nephrolithotomy
equivalent? J Endourol. 2011;25:481-85.
4. Jiang K, Zhang P, Xu B, et al. Percutaneous Nephrolithotomy vs.
Retrograde Intrarenal Surgery for Renal Stones Larger than 2cm in
Patients with a Solitary Kidney: A Systematic Review and a
Meta-Analysis. Urol J. 2020;28;17(5):442-48.
5. Koyuncu H, Yencilek F, Kalkan M, et al. Intrarenal Surgery vs
Percutaneous Nephrolithotomy in the Management of Lower Pole Stones
Greater than 2 cm. Int Braz J Urol. 2015;41: 245–51.
6. Aboumarzouk OM, Monga M, Kata SG, et al. Flexible ureteroscopy and
laser lithotripsy for stones > 2 cm: a systematic review
and meta-analysis. J Endourol. 2012;26: 1257-63.
7. Charlson M.E, Pompei P, Ales K.L, et al. A new methot of classifyning
prognostic comorbidity in longitudinal studies:developent and
validation. J Chronic Dis. 1987;40: pp. 373-83.
8. Deyo RA1, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index
for use with ICD-9-CM administrative databases. J Clin Epidemiol.1992;45: 613–19.
9. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a
combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.
10. Dindo D, Demartines N, Clavien PA. Classification of surgical
complications: a new proposal with evaluation in a cohort of 6336
patients and results of a survey. Ann Surg. 2004;240:205-13.
11. Tailly TO, Okhunov Z, Nadeau BR et al. Multicenter external
validation and comparison of stone scoring systems in predicting
outcomes after percutaneous nephrolithotomy. J Endourol.2016;30:594–601
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from
serum creatinine. Nephron. 1976;16:31-41.
13. Hu H, Lu Y, He D, et al. Comparison of minimally invasive
percutaneous nephrolithotomy and flexible ureteroscopy for the treatment
of intermediate proximal ureteral and renal stones in the elderly.Urolithiasis. 2016;44:427-34.
14. Sahan M, Sarilar O, Savun M, et al. Adopting for Supine Percutaneous
Nephrolithotomy: Analyzing the Learning Curve of Tertiary Academic
Center Urology Team. Urology. 2020;140:22-26.
15. Akman T, Binbay M, Ugurlu M, et al. Outcomes of retrograde
intrarenal surgery compared with percutaneous nephrolithotomy in elderly
patients with moderate-size kidney stones: a matched-pair analysis.J Endourol. 2015;26:625-29.
16. Gupta R, Mahajan A. Outcomes of percutaneous nephrolithotomy in
elderly versus young patients under regional anesthesia: A comparative
study. Urol Ann . 2020;12(3):254-58.
17. Knoll T, Jessen JP, Honeck P, et al. Flexible ureterorenoscopy
versus miniaturized PNL for solitary renal calculi of 10-30 mm
size.World J Urol. 2011;29(6):755-59.
18. Ozgor F, Yanaral F, Savun M, et al. Comparison of miniaturized
percutaneous nephrolithotomy and flexible ureterorenoscopy for moderate
size renal stones in elderly patients. Kaohsiung J Med Sci.2018;34(6):352-56.
19. Sabnis RB, Jagtap J, Mishra S, et al. Treating renal calculi 1–2 cm
in diameter with minipercutaneous or retrograde intrarenal surgery: a
prospective comparative study. BJU Int. 2012;110(8 Pt B):346–49.
20. Kirac M, Bozkurt OF, Tunc L, et al. Comparison of retrograde
intrarenal surgery and mini-percutaneous nephrolithotomy in management
of lower-pole renal stones with a diameter of smaller than 15 mm.Urolithiasis. 2013;41(3):241–46.
21. Pan J, Chen Q, Xue W, et al. RIRS versus mPCNL for single renal
stone of 2–3 cm: clinical outcome and cost-effective analysis in
Chinese medical setting. Urolithiasis. 2013;41(1):73–78.
22. Resorlu B, Diri A, Atmaca AF, et al. Can we avoid percutaneous
nephrolithotomy in high-risk elderly patients using the Charlson
comorbidity index? Urology . 2012;79(5):1042-47.
23. Unsal A, Resorlu B, Atmaca AF, et al. Prediction of morbidity and
mortality after percutaneous nephrolithotomy by using the Charlson
Comorbidity Index. Urology. 2012;79(1):55-60.
24. Okeke Z, Smith AD, Labate G, et al. Prospective comparison of
outcomes of percutaneous nephrolithotomy in elderly patients versus
younger patients. J Endourol. 2012;26:996-1001.
25. Karami H, Mazloomfard MM, Golshan A, et al. Does age affect outcomes
of percutaneous nephrolithotomy? Urol J . 2010;7:17-21.
26. Sahin A, Atsu N, Erdem E, et al. Percutaneous nephrolithotomy in
patients aged 60 years or older. J Endourol. 2011;15:489-91.
27. De la Rosette JJ, Zuazu JR, Tsakiris P, et al. Prognostic factors
and percutaneous nephrolithotomy morbidity: a multivariate analysis of a
contemporary series using the Clavien classification. J Urol.2008;180:2489-2493.
28. Tefekli A, Ali Karadag M, Tepeler K, et al. Classification of
percutaneous nephrolithotomy complications using the modified Clavien
grading system: looking for a standard. Eur Urol .
2008;53:184-190.
29. Aykac A, Baran O. Safety and efficacy of retrograde intrarenal
surgery in geriatric patients by age groups. Int Urol Nephrol.2020;52(12):2229-2236.
Table 1. Demographic and preoperative characteristics of the
patients